Characterization of cardiac repolarization in the Göttingen minipig

Journal of Pharmacological and Toxicological Methods

Volumn 63, Issue 2, 2011, Pages 186-195

  Laursen, Morten ^a,b   Olesen, Søren Peter ^b,c   Grunnet, Morten ^b,c   Mow, Tomas ^a   Jespersen, Thomas ^b  

^a University of Copenhagen ^*  (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c NEUROSEARCH A S   (Denmark)

Author keywords

Action potential; ECG; G ttingen minipig; Langendorff; Potassium channel; Temperature

Indexed keywords

BARIUM ION; BETA ADRENERGIC RECEPTOR; DELAYED RECTIFIER POTASSIUM CHANNEL; DOFETILIDE; INWARDLY RECTIFYING POTASSIUM CHANNEL; ISOPRENALINE; N [3 HYDROXY 2,2 DIMETHYL 6 (4,4,4 TRIFLUOROBUTOXY)CHROMAN 4 YL] N METHYLMETHANESULFONAMIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DENMARK; ENDOCARDIUM; EX VIVO STUDY; EXPERIMENTAL ANIMAL; FEMALE; GENE EXPRESSION; HEART ATRIUM; HEART MUSCLE POTENTIAL; HEART REPOLARIZATION; HEART VENTRICLE; IN VIVO STUDY; ISOLATED HEART; MALE; MINIPIG; NONHUMAN; TRIANGULATION;

ACTION POTENTIALS; ADRENERGIC BETA-AGONISTS; ANIMALS; CARDIAC ELECTROPHYSIOLOGY; CHROMANS; DELAYED RECTIFIER POTASSIUM CHANNELS; ENDOCARDIUM; FEMALE; HEART; HEART ATRIA; HEART CONDUCTION SYSTEM; HEART VENTRICLES; HUMANS; ION CHANNELS; ISOPROTERENOL; MALE; MODELS, ANIMAL; PHENETHYLAMINES; POTASSIUM; RNA, MESSENGER; SULFONAMIDES; SWINE; SWINE, MINIATURE;

ANIMALIA;

EID: 79951811311     PISSN: 10568719     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vascn.2010.10.001     Document Type: Article

References (49)

1. Attwell D., Cohen I., Eisner D.A. The effects of heart rate on the action potential of guinea-pig and human ventricular muscle. Journal de Physiologie 1981, 313:439-461.
2. Biliczki P., Virag L., Iost N., Papp J.G., Varro A. Interaction of different potassium channels in cardiac repolarization in dog ventricular preparations: Role of repolarization reserve. British Journal of Pharmacology 2002, 137:361-368.
3. Bosch R.F., Gaspo R., Busch A.E., Lang H.J., Li G.R., Nattel S. Effects of the chromanol 293B, a selective blocker of the slow, component of the delayed rectifier K+ current, on repolarization in human and guinea pig ventricular myocytes. Cardiovascular Research 1998, 38:441-450.
4. Calloe K., Soltysinska E., Jespersen T., Lundby A., Antzelevitch C., Olesen S.R.P., et al. Differential effects of the transient outward K+ current activator NS5806 in the canine left ventricle. Journal of Molecular and Cellular Cardiology 2010, 48:191-200.
5. Carmeliet E., Mubagwa K. Characterization of the acetylcholine-induced potassium current in rabbit cardiac Purkinje fibres. Journal of Physiology, London 1986, 371:219-237.
6. Crick S.J., Sheppard M.N., Ho S.Y., Gebstein L., Anderson R.H. Anatomy of the pig heart: Comparisons with normal human cardiac structure. Journal of Anatomy 1998, 193:105-119.
7. Ehrlich J.R., Hoche C., Coutu P., Metz-Weidmann C., Dittrich W., Hohnloser S.H., et al. Properties of a time-dependent potassium current in pig atrium: Evidence for a role of kv1.5 in repolarization. The Journal of Pharmacology and Experimental Therapeutics 2006, 319:898-906.
8. Franz M.R., Swerdlow C.D., Liem L.B., Schaefer J. Cycle length dependence of human action potential duration in vivo. Effects of single extrastimuli, sudden sustained rate acceleration and deceleration, and different steady-state frequencies. Journal of Clinical Investigation 1988, 82:972-979.
9. Gaborit N., Le B.S., Szuts V., Varro A., Escande D., Nattel S., et al. Regional and tissue specific transcript signatures of ion channel genes in the non-diseased human heart. Journal de Physiologie 2007, 582:675-693.
10. Gwilt M., Arrowsmith J.E., Blackburn K.J., Burges R.A., Cross P.E., Dalrymple H.W., et al. UK-68, 798: A novel, potent and highly selective class III antiarrhythmic agent which blocks potassium channels in cardiac cells. The Journal of Pharmacology and Experimental Therapeutics 1991, 256:318-324.
11. Hondeghem L.M., Carlsson L., Duker G. Instability and triangulation of the action potential predict serious proarrhythmia, but action potential duration prolongation is antiarrhythmic. Circulation 2001, 103:2004-2013.
12. Jacob M., Bruegger D., Rehm M., Welsch U., Conzen P., Becker B.F. Contrasting effects of colloid and crystalloid resuscitation fluids on cardiac vascular permeability. Anesthesiology 2006, 104:1223-1231.
13. Jost N., Papp J.G., Varro A. Slow delayed rectifier potassium current (IKs) and the repolarization reserve. Annals of Noninvasive Electrocardiology 2007, 12:64-78.
14. Jost N., Virag L., Bitay M., Takacs J., Lengyel C., Biliczki P., et al. Restricting excessive cardiac action potential and QT prolongation: A vital role for IKs in human ventricular muscle. Circulation 2005, 112:1392-1399.
15. Jurkiewicz N.K., Sanguinetti M.C. Rate-dependent prolongation of cardiac action potentials by a methanesulfonanilide class III antiarrhythmic agent. Specific block of rapidly activating delayed rectifier K+ current by dofetilide. Circulation Research 1993, 72:75-83.
16. Karjalainen J., Viitasalo M. Fever and cardiac rhythm. Archives of Internal Medicine 1986, 146:1169-1171.
17. Koller M.L., Riccio M.L., Gilmour R.F. Dynamic restitution of action potential duration during electrical alternans and ventricular fibrillation. The American Journal of Physiology 1998, 275:H1635-H1642.
18. Langendorff O. Untersuchungen am überlebenden Säugetierherzen. Pflügers Archiv 1895, 61:291-332.
19. Lathrop D.A., Contney S.J., Bosnjak Z.J., Stowe D.F. Reversal of hypothermia-induced action potential lengthening by the KATP channel agonist bimakalim in isolated guinea pig ventricular muscle. General Pharmacology 1998, 31:125-131.
20. Lengyel C., Dezsi L., Biliczki P., Horvath C., Virag L., Iost N., et al. Effect of a neuroprotective drug, eliprodil on cardiac repolarisation: Importance of the decreased repolarisation reserve in the development of proarrhythmic risk. British Journal of Pharmacology 2004, 143:152-158.
21. Li G.R., Du X.L., Siow Y.L., O, K., Tse H.F., Lau C.P. Calcium-activated transient outward chloride current and phase 1 repolarization of swine ventricular action potential. Cardiovascular Research 2003, 58:89-98.
22. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2-[delta][delta]CT method. Methods 2001, 25:402-408.
23. Lu Z., Kamiya K., Opthof T., Yasui K., Kodama I. Density and kinetics of IKr and IKs in guinea pig and rabbit ventricular myocytes explain different efficacy of IKs blockade at high heart rate in guinea pig and rabbit: Implications for arrhythmogenesis in humans. Circulation 2001, 104:951-956.
24. Malik M., Garnett C.E., Zhang J. Thorough QT studies: Questions and quandaries. Drug Safety 2010, 33:1-14.
25. Markert M., Stubhan M., Mayer K., Trautmann T., Klumpp A., Schuler-Metz A., et al. Validation of the normal, freely moving Gottingen minipig for pharmacological safety testing. Journal of Pharmacological and Toxicological Methods 2009, 60:79-87.
26. Mattu A., Brady W.J., Perron A.D. Electrocardiographic manifestations of hypothermia. The American Journal of Emergency Medicine 2002, 20:314-326.
27. Mortensen E., Berntsen R., Tveita T., Lathrop D.A., Refsum H. Changes in ventricular fibrillation threshold during acute hypothermia. A model for future studies. Journal of Basic and Clinical Physiology and Pharmacology 1993, 4:313-319.
28. Nerbonne J.M., Kass R.S. Molecular physiology of cardiac repolarization. Physiological Reviews 2005, 85:1205-1253.
29. Quadbeck J., Reiter M. Adrenoceptors in cardiac ventricular muscle and changes in duration of action potential caused by noradrenaline and isoprenaline. Naunyn-Schmiedeberg's Archives of Pharmacology 1975, 288:403-414.
30. Ravens U., Wettwer E. Electrophysiological aspects of changes in heart rate. Basic Research in Cardiology 1998, 93(Suppl 1):60-65.
31. Roche M., Renauleaud C., Ballet V., Doubovetzky M., Guillon J.M. The isolated rabbit heart and Purkinje fibers as models for identifying proarrhythmic liability. Journal of Pharmacological and Toxicological Methods 2010, 61:238-250.
32. Roden D.M. Taking the "idio" out of "idiosyncratic": Predicting torsades de pointes. Pacing and Clinical Electrophysiology 1998, 21:1029-1034.
33. Roden D.M. Drug-induced prolongation of the QT interval. The New England Journal of Medicine 2004, 350:1013-1022.
34. Roscher R., Arlock P., Sjoberg T., Steen S. Effects of dopamine on porcine myocardial action potentials and contractions at 37degrees C and 32degrees C. Acta Anaesthesiologica Scandinavica 2001, 45:421-426.
35. Sanguinetti M.C., Jiang C., Curran M.E., Keating M.T. A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell 1995, 81:299-307.
36. Sanguinetti M.C., Jurkiewicz N.K. Role of external Ca2+ and K+ in gating of cardiac delayed rectifier K+ currents. Pflugers Archiv 1992, 420:180-186.
37. Sanguinetti M.C., Jurkiewicz N.K., Scott A., Siegl P.K. Isoproterenol antagonizes prolongation of refractory period by the class III antiarrhythmic agent E-4031 in guinea pig myocytes. Mechanism of action. Circulation Research 1991, 68:77-84.
38. Sanguinetti M.C., Tristani-Firouzi M. hERG potassium channels and cardiac arrhythmia. Nature 2006, 440:463-469.
39. Soltysinska E., Olesen S.P., Christ T., Wettwer E., Varro A., Grunnet M., et al. Transmural expression of ion channels and transporters in human nondiseased and end-stage failing hearts. Pflugers Archiv 2009, 459:11-23.
40. Stubhan M., Markert M., Mayer K., Trautmann T., Klumpp A., Henke J., et al. Evaluation of cardiovascular and ECG parameters in the normal, freely moving Göttingen minipig. Journal of Pharmacological and Toxicological Methods 2008, 57:202-211.
41. Svendsen O. The minipig in toxicology. Experimental and Toxicologic Pathology 2006, 57:335-339.
42. Swindle M.M., Smith A.C. Comparative anatomy and physiology of the pig. Scandinavian Journal of Laboratory Animal Science 1998, 25:1-10.
43. Thomas G., Gerlach U., Antzelevit C. HMR 1556, a potent and selective blocker of slowly activating delayed rectifier potassium current. Journal of Cardiovascular Pharmacology 2003, 41:140-147.
44. Thomsen M.B., Wang C., Ozgen N., Wang H.G., Rosen M.R., Pitt G.S. Accessory subunit KChIP2 modulates the cardiac L-type calcium current. Circulation Research 2009, 104:1382-1389.
45. Van de Water A., Verheyen J., Xhonneux R., Reneman R.S. An improved method to correct the QT interval of the electrocardiogram for changes in heart rate. Journal of Pharmacological Methods 1989, 22:207-217.
46. van der Linde H.J., Van D.B., Teisman A., Towart R., Gallacher D.J. The effect of changes in core body temperature on the QT interval in beagle dogs: A previously ignored phenomenon, with a method for correction. British Journal of Pharmacology 2008, 154:1474-1481.
47. Volders P.G.A., Stengl M., van Opstal J.M., Gerlach U., Spatjens R.L.H.M., Beekman J.D.M., et al. Probing the contribution of IKs to canine ventricular repolarization: Key role for {beta}-adrenergic receptor stimulation. Circulation 2003, 107:2753-2760.
48. Weerapura M., Nattel S., Courtemanche M., Doern D., Ethier N., Hebert T. State-dependent barium block of wild-type and inactivation-deficient HERG channels in Xenopus oocytes. Journal de Physiologie 2000, 526(Pt 2):265-278.
49. Wu M.H., Su M.J., Sun S.S.M. Electrophysiological profile after inward rectifier K channel blockade by barium in isolated rabbit hearts. Altered repolarization and unmasked decremental conduction property. Europace 1999, 1:85-95.